Treatment of Hypothyroidism
Standard thyroid hormone replacement therapy with levothyroxine is the recommended treatment for hypothyroidism, with dosing based on patient characteristics and severity of disease.
Diagnosis and Evaluation
- Diagnosis of hypothyroidism is based on biochemical testing with elevated TSH and low free T4 levels indicating overt primary hypothyroidism 1, 2
- Both TSH and free T4 should be measured for accurate diagnosis, especially in symptomatic patients 1
- Low TSH with low free T4 suggests central hypothyroidism, which requires evaluation for hypophysitis 1
Treatment Algorithm
Initial Levothyroxine Dosing
For young, healthy patients without cardiovascular disease:
For elderly patients (>70 years) or those with cardiac disease:
Monitoring and Dose Adjustment
- Check TSH and free T4 levels 6-8 weeks after initiating therapy or changing dose 1, 3
- Adjust dose by 12.5-25 mcg if TSH remains above reference range 1
- Target TSH within normal reference range 1, 2
- After achieving stable maintenance dose, monitor annually or sooner if patient's clinical status changes 1
Special Populations
Pregnancy:
Subclinical Hypothyroidism Management:
Management Based on Severity
Mild to Moderate Hypothyroidism (Grade 1-2)
- Continue thyroid hormone replacement therapy 1
- For symptomatic patients with any degree of TSH elevation: Start levothyroxine 1
- For asymptomatic patients with TSH >10 mIU/L: Start levothyroxine 1
Severe Hypothyroidism (Grade 3-4)
- Hospitalize patients with myxedema coma (bradycardia, hypothermia, altered mental status) 1
- Consult endocrinology for rapid hormone replacement 1
- If uncertain whether primary or central hypothyroidism is present, give hydrocortisone before starting thyroid hormone 1
Common Pitfalls and Considerations
- Overtreatment can lead to subclinical hyperthyroidism, increasing risk of atrial fibrillation and osteoporosis, especially in elderly 4
- Development of low TSH on therapy suggests overtreatment or recovery of thyroid function; reduce dose or discontinue with close follow-up 1
- Adding T3 (triiodothyronine) is generally not recommended, even in patients with persistent symptoms and normal TSH levels 5, 6
- Elevated TSH can be seen in recovery phase of thyroiditis; in asymptomatic patients with normal free T4, consider monitoring for 3-4 weeks before treating 1
- Patients with persistent symptoms despite normalized TSH should be evaluated for other causes 5
Long-term Management
- Levothyroxine is generally continued for life in patients with permanent hypothyroidism 4, 2
- Annual monitoring of TSH is recommended once stable dosage is achieved 1, 2
- Untreated or undertreated hypothyroidism can lead to serious complications including cardiovascular disease, insulin resistance, and increased mortality 2, 6